Neuronetics, Inc. — Director's Dealing 2018

Jul 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Neuronetics, Inc. (STIM)
CIK: 0001227636
Period of Report: 2018-07-02

Reporting Person: Farley Brian E (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-07-02	Common Stock	C	8483	—	Acquired	84065	Direct
2018-07-02	Common Stock	C	15342	—	Acquired	99407	Direct
2018-07-02	Common Stock	C	9525	—	Acquired	108932	Direct
2018-07-02	Common Stock	C	1506	—	Acquired	110438	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-02	Series D Covertible Preferred Stock	$	C	8483	Disposed		Common Stock (8483)	Direct
2018-07-02	Series E Covertible Preferred Stock	$	C	15342	Disposed		Common Stock (15342)	Direct
2018-07-02	Series F Covertible Preferred Stock	$	C	9525	Disposed		Common Stock (9525)	Direct
2018-07-02	Series G Covertible Preferred Stock	$	C	1506	Disposed		Common Stock (1506)	Direct
2018-07-02	Stock Option Grant (Right to Buy)	$5.22	A	10959	Acquired	2028-04-25	Common Stock (10959)	Direct

Footnotes

F1: Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering.

F2: The performance criterion for vesting of this option was met upon the closing of the Issuer's initial public offering. One twelfth (1/12th) of the shares subject to the option vested or shall vest monthly commencing on March 16, 2018, subject to Reporting Person continuing to provide service through each such date.